TNDM R&D to Revenue
Tandem Diabetes Care Inc · R&D to Revenue
TNDM R&D to Revenue
Latest reported18.44%period ending
TNDM Quarterly R&D/Revenue (969.04% → 18.44%)
Latest values, visible window
High-resolution chart · PNG
TNDM r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 18.4357% | |
| 18.621% | |
| 15.8639% | |
| 19.2106% | |
| 19.9927% | |
| 53.5069% | |
| 18.4682% | |
| 14.0679% | |
| 22.2279% | |
| 24.1264% | |
| 21.6488% | |
| 22.6105% | |
| 21.9139% | |
| 71.3826% | |
| 16.1487% | |
| 33.1533% | |
| 16.7635% | |
| 18.8509% | |
| 14.0441% | |
| 13.4178% | |
| 11.9084% | |
| 12.735% | |
| 10.3389% | |
| 13.0207% | |
| 14.6353% | |
| 14.416% | |
| 11.5934% | |
| 12.7175% | |
| 12.0144% | |
| 14.2268% | |
| 11.5448% | |
| 17.2899% | |
| 18.9181% | |
| 21.9049% | |
| 14.2726% | |
| 18.198% | |
| 22.8161% | |
| 27.0327% | |
| 15.0249% | |
| 50.061% | |
| 18.0204% | |
| 20.7847% | |
| 14.1518% | |
| 32.4065% | |
| 24.6594% | |
| 31.3861% | |
| 21.9241% | |
| 33.3587% | |
| 36.0605% | |
| 45.4198% | |
| 32.6657% | |
| 34.0989% | |
| 49.9075% | |
| 42.5486% | |
| 88.1393% | |
| 969.0429% |